The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,396 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | 1,356 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 3,426 | 352,500 | SH | SOLE | 352,500 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 11,628 | 125,087 | SH | SOLE | 125,087 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 5,616 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 4,558 | 493,278 | SH | SOLE | 493,278 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 4,237 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 4,154 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,078 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 3,909 | 145,000 | SH | Call | SOLE | 145,000 | 0 | 0 | |
| CELULARITY INC | COM CL A | 151190105 | 624 | 183,600 | SH | Put | SOLE | 183,600 | 0 | 0 | |
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 16,398 | 937,568 | SH | SOLE | 937,568 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 1,128 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 1,873 | 883,654 | SH | SOLE | 883,654 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 4,254 | 70,000 | SH | Call | SOLE | 70,000 | 0 | 0 | |
| CURIS INC | COM NEW | 231269200 | 335 | 340,349 | SH | SOLE | 340,349 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 4,048 | 1,372,244 | SH | SOLE | 1,372,244 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 589 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| ENOCHIAN BIOSCIENCES INC | COM | 29350E104 | 386 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 19,574 | 359,956 | SH | SOLE | 359,956 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 8,157 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
| FATE THERAPEUTICS INC | COM | 31189P102 | 1,673 | 67,500 | SH | Call | SOLE | 67,500 | 0 | 0 | |
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 5,982 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 382 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
| INARI MED INC | COM | 45332Y109 | 15,106 | 222,173 | SH | SOLE | 222,173 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,656 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 5,693 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 5,693 | 45,000 | SH | Put | SOLE | 45,000 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 17,015 | 928,256 | SH | SOLE | 928,256 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 9,244 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 4,622 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 2,750 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| LIANBIO | SPONSORED ADS | 53000N108 | 972 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| LILLY ELI & CO | COM | 532457108 | 9,727 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 7,158 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 8 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 2,143 | 15,000 | SH | Call | SOLE | 15,000 | 0 | 0 | |
| MORPHIC HLDG INC | COM | 61775R105 | 4,681 | 215,723 | SH | SOLE | 215,723 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 8,019 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 1,255 | 466,607 | SH | SOLE | 466,607 | 0 | 0 | ||
| NOVAVAX INC | COM NEW | 670002401 | 4,629 | 90,000 | SH | Put | SOLE | 90,000 | 0 | 0 | |
| NOVAVAX INC | COM NEW | 670002401 | 4,372 | 85,000 | SH | Call | SOLE | 85,000 | 0 | 0 | |
| POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 174 | 25,578 | SH | SOLE | 25,578 | 0 | 0 | ||
| RENOVACOR INC | COM | 75989E106 | 405 | 199,490 | SH | SOLE | 199,490 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 5 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 4,494 | 321,200 | SH | SOLE | 321,200 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 3,446 | 250,466 | SH | SOLE | 250,466 | 0 | 0 | ||
| SCIENCE 37 HOLDINGS INC | COM | 808644108 | 562 | 279,775 | SH | SOLE | 279,775 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 721 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 995 | 401,268 | SH | SOLE | 401,268 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 10,901 | 11,000,000 | PRN | SOLE | 11,000,000 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 1,814 | 1,374,098 | SH | SOLE | 1,374,098 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 239 | 20,660 | SH | SOLE | 20,660 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 1,967 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||